These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 10357393)

  • 1. Gemfibrozil effectively lowers protease inhibitor-associated hypertriglyceridemia in HIV-1-positive patients.
    Hewitt RG; Shelton MJ; Esch LD
    AIDS; 1999 May; 13(7):868-9. PubMed ID: 10357393
    [No Abstract]   [Full Text] [Related]  

  • 2. A randomized, double-blind study of gemfibrozil for the treatment of protease inhibitor-associated hypertriglyceridaemia.
    Miller J; Brown D; Amin J; Kent-Hughes J; Law M; Kaldor J; Cooper DA; Carr A
    AIDS; 2002 Nov; 16(16):2195-200. PubMed ID: 12409741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sexual dysfunction secondary to gemfibrozil.
    James CW; Wu TS; McNelis KC
    Pharmacotherapy; 2002 Jan; 22(1):123-5. PubMed ID: 11794424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Updates from the 38th Interscience Conference on Antimicrobial Agents and Chemotherapy.
    Whitson S
    Posit Aware; 1998; 9(6):18-9. PubMed ID: 11366473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative effectiveness of fish oil versus fenofibrate, gemfibrozil, and atorvastatin on lowering triglyceride levels among HIV-infected patients in routine clinical care.
    Muñoz MA; Liu W; Delaney JA; Brown E; Mugavero MJ; Mathews WC; Napravnik S; Willig JH; Eron JJ; Hunt PW; Kahn JO; Saag MS; Kitahata MM; Crane HM
    J Acquir Immune Defic Syndr; 2013 Nov; 64(3):254-60. PubMed ID: 23892238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Statins and fibrates for the treatment of hyperlipidaemia in HIV-infected patients receiving HAART.
    Calza L; Manfredi R; Chiodo F
    AIDS; 2003 Apr; 17(6):851-9. PubMed ID: 12660532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Andrographis paniculata Extract on Triglyceride Levels of the Patients with Hypertriglyceridemia: A Randomized Controlled Trial.
    Phunikhom K; Khampitak K; Aromdee C; Arkaravichien T; Sattayasai J
    J Med Assoc Thai; 2015 Jul; 98 Suppl 6():S41-7. PubMed ID: 26434249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of fibrates in the management of hyperlipidemia in HIV-infected patients receiving HAART.
    Calza L; Manfredi R; Chiodo F
    Infection; 2002 Jan; 30(1):26-31. PubMed ID: 11876511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of protease inhibitor-associated hyperlipidemia.
    Penzak SR; Chuck SK
    Am J Cardiovasc Drugs; 2002; 2(2):91-106. PubMed ID: 14727985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Summaries for patients. Response to cholesterol-lowering drugs in patients with and without HIV infection.
    Ann Intern Med; 2009 Mar; 150(5):I38. PubMed ID: 19258553
    [No Abstract]   [Full Text] [Related]  

  • 11. Gemfibrozil treatment of hypertriglyceridemia: improvement on fibrinolysis without change of insulin resistance.
    Jeng JR; Jeng CY; Sheu WH; Lee MM; Huang SH; Shieh SM
    Am Heart J; 1997 Sep; 134(3):565-71. PubMed ID: 9327717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gemfibrozil treatment of endogenous hypertriglyceridemia: effect on insulin-mediated glucose disposal and plasma insulin concentrations.
    Jeng CY; Sheu WH; Fuh MM; Shieh SM; Chen YD; Reaven GM
    J Clin Endocrinol Metab; 1996 Jul; 81(7):2550-3. PubMed ID: 8675576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of gemfibrozil upon the metabolism of chylomicron-like emulsions in patients with endogenous hypertriglyceridemia.
    Santos RD; Ventura LI; Spósito AC; Schreiber R; Ramires JA; Maranhão RC
    Cardiovasc Res; 2001 Feb; 49(2):456-65. PubMed ID: 11164856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of Serum Triglyceride Level and Gemfibrozil Consumption With Periodontal Status.
    Sayar F; Akhondi N; Fallah S; Moalemnia AA; Cheraghi A
    J Periodontol; 2017 May; 88(5):457-463. PubMed ID: 27958766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Response to newly prescribed lipid-lowering therapy in patients with and without HIV infection.
    Silverberg MJ; Leyden W; Hurley L; Go AS; Quesenberry CP; Klein D; Horberg MA
    Ann Intern Med; 2009 Mar; 150(5):301-13. PubMed ID: 19258558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rhabdomyolysis after cerivastatin-gemfibrozil therapy in an HIV-infected patient with protease inhibitor-related hyperlipidemia.
    Mastroianni CM; d'Ettorre G; Forcina G; Lichtner M; Corpolongo A; Coletta S; Vullo V
    AIDS; 2001 Apr; 15(6):820-1. PubMed ID: 11371708
    [No Abstract]   [Full Text] [Related]  

  • 17. Combination of gemfibrozil and orlistat for treatment of combined hyperlipidemia with predominant hypertriglyceridemia.
    Tolentino MC; Ferenczi A; Ronen L; Poretsky L
    Endocr Pract; 2002; 8(3):208-12. PubMed ID: 12113634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Commentary. Secondary causes of hypertriglyceridemia and pancreatitis.
    Wagh A; Stone NJ
    Clin Chim Acta; 2003 Jun; 332(1-2):21. PubMed ID: 12763275
    [No Abstract]   [Full Text] [Related]  

  • 19. Ritonavir, triglycerides, and pancreatitis.
    Perry RC; Cushing HE; Deeg MA; Prince MJ
    Clin Infect Dis; 1999 Jan; 28(1):161-2. PubMed ID: 10028103
    [No Abstract]   [Full Text] [Related]  

  • 20. Use of fenofibrate in the management of protease inhibitor-associated lipid abnormalities.
    Thomas JC; Lopes-Virella MF; Del Bene VE; Cerveny JD; Taylor KB; McWhorter LS; Bultemeier NC
    Pharmacotherapy; 2000 Jun; 20(6):727-34. PubMed ID: 10853629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.